Answers are grounded in this paper and cite their sources.
Reactions produce di-Cu(I) phthalimides in dicyanoarenes, suggesting robust bonding for ligand modifications.
The reactions of [Cu2(μ–κ1:κ1-O2N)DPFN][NTf2] (1; DPFN = 2,7-bis(fluoro-di(2-pyridyl)methyl)-1,8-naphthyridine, NTf2– = N(SO2CF3)2–) with 1,4-dicyanobenzene and 1,2-dicyanoarenes are discussed. Treatment of 1 with 1,4-dicyanobenzene produces a tetra-Cu(I) terephthalate complex (2) and dinitrogen via a discrete C≡N triple bond cleavage at each cyano group. However, reactions of 1 with 1,2-dicyanoarenes appear to proceed via a cascade reaction involving two intertwined C≡N triple bond activations to yield a series of di-Cu(I) phthalimides, [Cu2(μ–N(CO)2(Ar))DPFN][NTf2] (3-(Ar); Ar = 1,2-arylenes C6H4, 3-NO2C6H3, 4-NO2C6H3, 4-PrOC6H3, 3-NC5H3) and dinitrogen. The dicopper phthalimide bonding interaction in these compounds is robust enough to resist protonation by pentafluorophenol and alkylation by methyl triflate or benzyl chloride at the imide nitrogen. This characteristic presents an opportunity for postsynthetic modifications of the phthalimide ligand. Nevertheless, treatment of 3-(C6H4) with bistriflimidic acid (HNTf2) results in release of the neutral phthalimide, making the dicopper core available to coordinate other ligands such as nitrite and thus, completing a stoichiometric cycle.
No takes yet. Share an insight, caveat, or question.
Fernandez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: